Reduction of night/day difference in melatonin blood levels as a possible disease-related index in schizophrenia

Neuroendocrinology Letters

Volumn 24, Issue 3-4, 2003, Pages 181-184

  Bersani, Giuseppe ^a   Mameli, Monica ^a   Garavini, Alessandra ^a   Pancheri, Paolo ^a   Nordio, Maurizio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Circadian rhythm; Index; Melatonin; Psychopathology; Schizophrenia

Indexed keywords

MELATONIN; PINEAL BODY HORMONE;

ADULT; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; LIGHT DARK CYCLE; MALE; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 0041785427     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Geoffriau M, Brun J, Chazot G, Claustrat B. The physiology and pharmacology of melatonin in humans. Horm Res 1998; 49:136-141.
2. Miles A, Philbrick DRS. Melatonin and Psychiatry. Biol Psychiatry 1988; 23:405-425.
3. McIsaac WM. A biochemical concept of mental illness. Post-grad Medicine 1961; 30:111-118.
4. Smythies JR. Recent progress in schizophrenia research. Lancet 1976; ii:136-139.
5. Ferrier IN, Arendt J, Johnstone EC, Crow TJ. Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clin Endocrinol 1982; 17:181-187.
6. Fanget F, Claustrat B, Dalery J, Brun J, Terra JL, Marie-Cardine M, Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry 1989; 25:499-501.
7. Robinson S, Rosca P, Durst R, Shai U, Ghinea C, Schmidt U, Nir I. Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients. Acta Psychiatrica Scand 1991; 84:221-224.
8. Jiang HK, Wang JY. Diurnal melatonin and cortisol secretion profiles in medicated schizophrenic patients. J Formos Med Assoc 1998; 97:830-837.
9. Monteleone P, Natale M, La Rocca A, Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 1997; 36:159-63.
10. Rao ML, Gross G, Strebel B, Halaris A, Huber G, Braunig P, Marler M. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994; 35:151-163.
11. Bersani G, Garavini A, Taddei I, Tanfani G, Nordio M, Pancheri P. Computed tomography study of pineal calcification in schizophrenia. Eur Psychiatry 1999; 14:163-166.
12. Bersani G, Garavini A, Iannitelli A, Quartini A, Nordio M, Di Biasi C, Pancheri P. Reduced pineal volume in male patients with schizophrenia: no relationship to clinical features of the illess. Neuroscience Letters 2002; 30:246.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV Edition (DSM-IV). American Psychiatric Association. Washington DC; 1994.
14. Fraser S, Cowen P, Franklin M, Franey C, Arendt J. Clinical Chemistry 1983; 29:396-397.
15. Andreasen NC and Olsen SA. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 1982; 39:789-794.
16. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989; 155:59-65.
17. Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res 1992; 7:77-84.
18. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 2001; 21: 605-16.
19. Van Cauter E, Linkowski P, Kerkhofs M, Hubain P, L'Hermite-Baleriaux M, Leclercq R, Brasseur M, Copinschi G, Mendlewicz J. Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry 1991; 48:348-56.